These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11986965)

  • 1. Comment on 'Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes' by S Tauro et al.
    Mundle SD
    Leukemia; 2002 May; 16(5):960-1; author reply 961. PubMed ID: 11986965
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes.
    Tauro S; Hepburn MD; Peddie CM; Bowen DT; Pippard MJ
    Leukemia; 2002 May; 16(5):785-90. PubMed ID: 11986938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
    Tauro S; Hepburn MD; Bowen DT; Pippard MJ
    Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
    Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
    J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathology of myelodysplastic syndromes: biology of medullary stromal and hematopoietic cells (review).
    Kitagawa M; Kurata M; Yamamoto K; Abe S; Suzuki S; Umeda S
    Mol Med Rep; 2011; 4(4):591-6. PubMed ID: 21584497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of bone marrow stromal abnormalities in a patient with constitutional trisomy 8 mosaicism and myelodysplastic syndrome.
    Narendran A; Hawkins LM; Ganjavi H; Vanek W; Gee MF; Barlow JW; Johnson G; Malkin D; Freedman MH
    Pediatr Hematol Oncol; 2004; 21(3):209-21. PubMed ID: 15202160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional characteristics of hematopoietic and stromal cells in various forms of myelodysplastic syndrome].
    Gerasimova LP; Manakova TE; Tsvetaeva NV; Lukina EA; Kozlovskaia AS
    Biull Eksp Biol Med; 1999 Jan; 127(1):14-8. PubMed ID: 10189996
    [No Abstract]   [Full Text] [Related]  

  • 8. The geldanamycin derivative 17-AAG decreases VEGF secretion and leukemia growth support by trisomy 8 myelodysplastic syndrome bone marrow stromal cells.
    Hawkins LM; Narendran A
    Pediatr Hematol Oncol; 2005 Mar; 22(2):115-25. PubMed ID: 15804996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The myelodysplastic syndromes: a matter of life or death.
    Parker JE; Mufti GJ
    Acta Haematol; 2004; 111(1-2):78-99. PubMed ID: 14646347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-chemotherapy and cytokine pretreated marrow stromal cell layers suppress hematopoiesis from normal donor CD34+ cells.
    Schwartz GN; Warren MK; Rothwell SW; Zujewski J; Halverson DC; Cowan KH; Tolcher A; O'Shaughnessy J; Gress RE
    Bone Marrow Transplant; 1998 Sep; 22(5):457-68. PubMed ID: 9733269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis in MDS: a new perspective.
    Mundle SD
    Cancer Treat Res; 2001; 108():101-9. PubMed ID: 11702596
    [No Abstract]   [Full Text] [Related]  

  • 12. [The hematopoietic stem cell and the stromal microenvironment].
    Charbord P
    Therapie; 2001; 56(4):383-4. PubMed ID: 11677858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow stromal culture from patients with myelodysplastic syndromes and patients at different stages of acute nonlymphocytic leukaemia.
    Elstner E; Wächter M; Ihle R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):167-74. PubMed ID: 2472321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic analysis of the ability of stromal cell lines derived from different murine adult tissues to support maintenance of hematopoietic stem cells in vitro.
    Rios M; Williams DA
    J Cell Physiol; 1990 Dec; 145(3):434-43. PubMed ID: 1703166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro biology of the hematopoietic system in myelodysplastic syndromes.
    Mayani H
    Cancer Treat Res; 2001; 108():25-43. PubMed ID: 11702602
    [No Abstract]   [Full Text] [Related]  

  • 16. Defective adhesion and homing of hemopoietic precursors from the bone marrow of patients with myelodysplasia to stromal cells of normal bone marrow cultures.
    Manakova TE; Tsvetaeva NV; Belkin VM; Momotyuk KS; Khoroshko ND
    Bull Exp Biol Med; 2005 Jan; 139(1):7-10. PubMed ID: 16142262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preleukemic states: an experimental murine model for myelodysplastic human syndromes].
    Defresne MP
    Bull Mem Acad R Med Belg; 2001; 156(1-2):99-104; discussion 105-6. PubMed ID: 11697189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients.
    Gidáli J; Fehér I; Hollán SR
    Stem Cells; 1996 Sep; 14(5):577-83. PubMed ID: 8888498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Cx43 gene-modified leukemic bone marrow stromal cells on the regulation of Jurkat cell line in vitro.
    Zhang X; Liu Y; Si YJ; Chen XH; Li ZJ; Gao L; Gao L; Zhang C
    Leuk Res; 2012 Feb; 36(2):198-204. PubMed ID: 22030334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Images in clinical medicine. Apoptosis in myelodysplastic syndromes.
    Lambertenghi Deliliers G; Caneva L
    N Engl J Med; 1999 May; 340(21):1639. PubMed ID: 10341276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.